This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Follow-up after insertion of an IUCD

Authoring team

Routine follow-up

  • at 3-6 weeks to check threads and exclude perforation
  • return if problems or time for removal; no further follow-up needed

At first follow-up visit exclude infection, perforation or expulsion

Intrauterine device (IUD) only: For heavier and/or prolonged bleeding associated with use of an IUD:

  • treat with non-steroidal anti-inflammatory drugs and tranexamic acid
  • or suggest changing to the IUS if the woman finds bleeding unacceptable

If Actinomyces-like organisms are seen on a cervical smear, assess for pelvic infection, and remove the IUD or intrauterine system (IUS) (Mirena coil) if there are signs of infection

If a woman becomes pregnant with an intrauterine pregnancy, advise removal of the IUD or IUS before 12 weeks' gestation, whether or not she intends to continue the pregnancy

Reference:

  1. NICE (2014). Long-acting reversible contraception

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.